Zocor and Resorption bone increased - a phase IV clinical study of FDA data

Summary:

Resorption bone increased is reported as a side effect among people who take Zocor (simvastatin), especially for people who are female, 60+ old, also take Fosamax, and have Osteoporosis.

The phase IV clinical study analyzes which people have Resorption bone increased when taking Zocor. It is created by eHealthMe based on reports of 84,616 people who have side effects when taking Zocor from the FDA, and is updated regularly.

What is Zocor?

Zocor has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 86,545 Zocor users. Check the latest studies of Zocor.

What is Resorption bone increased?

Resorption bone increased is found to be associated with 236 drugs and 262 conditions by eHealthMe. Check the latest studies of Resorption bone increased.

On Jul, 18, 2026

84,616 people reported to have side effects when taking Zocor.
Among them, 54 people (0.06%) have Resorption bone increased.

Could Zocor cause Resorption bone increased?

Among these 54 people:

What is the gender of people who have Resorption bone increased when taking Zocor? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Resorption bone increased when taking Zocor? *

What are other drugs people take besides Zocor? *

What are other side effects people have besides Resorption bone increased? *

Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 40 people, 74.07%
Bone Disorder: 29 people, 53.70%
Stress And Anxiety: 28 people, 51.85%
Pain: 27 people, 50.00%
Loose Tooth: 23 people, 42.59%
Deformity (disfigurement): 17 people, 31.48%
Swelling: 17 people, 31.48%
Emotional Distress: 16 people, 29.63%
Tooth Disorder (tooth disease): 16 people, 29.63%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 16 people, 29.63%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 17 people, 31.48%
Multiple Myeloma (cancer of the plasma cells): 12 people, 22.22%
Prostate Cancer: 9 people, 16.67%
Metastases To Bone (cancer spreads to bone): 9 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 12.96%
Pain: 6 people, 11.11%
Osteopenia (a condition where bone mineral density is lower than normal): 5 people, 9.26%
Prostatitis (inflammation of the prostate gland): 5 people, 9.26%
Fatigue (feeling of tiredness): 5 people, 9.26%
Arthropod Sting (arthropod bite): 4 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Zocor and have Resorption bone increased?

- Check whether Resorption bone increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zocor:

Zocor (86,545 reports)

Browse all side effects of Zocor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Resorption bone increased:

Resorption bone increased (236 drugs)

Browse all the conditions that are associated with Resorption bone increased:

Resorption bone increased (262 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on simvastatin (the active ingredients of Zocor) and Zocor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.